Press Releases PolyPid Ltd.

Equities

PYPD

IL0011326795

Delayed Nasdaq Other stock markets 19:07:34 08/05/2024 BST			5-day change	1st Jan Change
4.31 ^USD	-11.32%		-13.80%	+13.42%

04-30	PolyPid Ltd. Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections	CI
02-14	Transcript : PolyPid Ltd., Q4 2023 Earnings Call, Feb 14, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results	12:02pm	AQ
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX for the Prevention of Abdominal Colorectal Surgical Site Infections	05-01	AQ
PolyPid to Participate in Citizens JMP Life Sciences Conference	05-01	AQ
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections	04-30	AQ
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024	04-24	AQ
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference	02-28	AQ
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	02-14	AQ
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial	02-12	AQ
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024	01-31	AQ
PolyPid Announces Private Placement for $16 Million in Gross Proceeds	01-04	AQ
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results	11-08	AQ
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors	11-07	AQ
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023	11-01	AQ
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule	11/10/23	AQ
POLYPID : AMENDED AND RESTATED 2012 SHARE OPTION PLAN - Form 6-K	10/10/23	PU
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023	09/10/23	AQ
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX and PLEX Technology Platform	05/10/23	AQ
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform	04/10/23	AQ
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference	25/09/23	AQ
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference	22/09/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases PolyPid Ltd.

Equities

PYPD

IL0011326795

Press Releases

Filters